Carbubarb
Systematic (IUPAC) name | |
---|---|
2-(5-butyl-2,4,6-trioxo-1,3-diazinan-5-yl)ethyl carbamate | |
Clinical data | |
Trade names | Nogexan |
Identifiers | |
960-05-4 | |
None | |
PubChem | CID 13743 |
ChemSpider | 13148 |
UNII | SIW4YR11ST |
ChEMBL | CHEMBL2104020 |
Synonyms | Carbubarbital |
Chemical data | |
Formula | C11H17N3O5 |
271.270 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
Carbubarb (Carbubarbital, trade name Nogexan) is a carbamate-substituted barbiturate derivative, which has sedative effects.[1]
References
- ↑ US patent 4428887, Tou, J. S. & Schleppnik, A. A., "Method of producing mono-substituted terminal diesters", issued 1984-01-31, assigned to Monsanto
|